Loading...
•
Sep 30, 2022
Zimmer Biomet Q3 2022 Earnings Report
Announced third quarter 2022 financial results.
Key Takeaways
Zimmer Biomet's third quarter net sales were $1.670 billion, a decrease of 0.9% over the prior year, but increased 5.0% on a constant currency basis. Net earnings were $194.0 million, or $333.1 million on an adjusted basis. Diluted earnings per share were $0.92, and adjusted diluted earnings per share were $1.58.
Third quarter net sales from continuing operations of $1.670 billion decreased 0.9% and increased 5.0% on a constant currency basis
Third quarter diluted earnings per share from continuing operations were $0.92; adjusted diluted earnings per share from continuing operations were $1.58
Company updates 2022 financial guidance, raising range for full year outlook
Aligned with the ongoing transformation of Zimmer Biomet's business, key third quarter highlights include announcement of a first-of-its-kind, three-year agreement with Hospital for Special Surgery (HSS) to create the HSS/Zimmer Biomet (ZB) Innovation Center for Artificial Intelligence (AI) in Robotic Joint Replacement
Revenue by Segment
Forward Guidance
Company updates 2022 financial guidance, raising range for full year outlook
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...